<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Adenoviral-Vector-Gene-Therapy on 生物经济</title><link>https://cn.bioecon.ru/technologies/adenoviral-vector-gene-therapy/</link><description>Recent content in Adenoviral-Vector-Gene-Therapy on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Fri, 25 Sep 2026 20:15:59 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/technologies/adenoviral-vector-gene-therapy/index.xml" rel="self" type="application/rss+xml"/><item><title>腺病毒载体基因治疗</title><link>https://cn.bioecon.ru/technology/adenoviral-vector-gene-therapy/</link><pubDate>Fri, 18 Sep 2026 14:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/adenoviral-vector-gene-therapy/</guid><description>复制缺陷型腺病毒载体在工业规模上递送疫苗抗原与治疗基因——经大流行试验验证的平台家族、2,000 升悬浮生物反应器，以及供养它们的质粒到载体 GMP 链。表中四家供应商的台账均带完整来源链。</description></item></channel></rss>